Study of DXC008 for advanced prostate and other solid tumors
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new drug called DXC008 for people with advanced solid tumors, including prostate cancer, that have not responded to standard treatments. The goal is to see if it can help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced solid tumor or prostate cancer that has not responded to standard treatment.
- You are 18 to 75 years old.
- Your overall health is good enough to carry out daily activities (ECOG score 0-2).
- Your blood counts, liver, kidney, and heart function are within certain limits.
- You have not had recent major surgery, serious heart issues, or active infections.
- For prostate cancer: your testosterone level is very low (≤50 ng/dL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests DXC014, a new drug, in people with advanced solid tumors, including prostate cancer. It aims to see if the drug is safe and effective.
This trial tests a new drug called DXC018 for people with advanced solid tumors that have not responded to standard treatments or for whom no standard treatment exists. The goal is to see if the drug can shrink or slow the growth of these tumors.
This trial tests a new drug, DXC006, for people with advanced solid tumors or blood cancers like multiple myeloma and neuroblastoma that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests an investigational drug called DXP-106 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the cancer.
This trial tests a new drug called CX-801 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new drug called MDX2004 for people with advanced solid tumors (cancer that has spread or can't be removed). The goal is to see if the drug is safe and if it helps shrink tumors.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.